Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

7 Healthcare Programmatic Advertising Best Practices

February 14, 2024

Whether you're looking to boost patient engagement, increase provider awareness, or maximize your ROI, Health Union has the insights to take your programmatic advertising to the next level.

Medical Device Advertising Regulations: What to Know

December 8, 2023

Right now, medical device advertising doesn’t come with a ton of red tape — at least not as much as you’d think,

Healthcare Geofencing: The What & Why

November 20, 2023

Healthcare geofencing campaigns use programmatic technology that leverages GPS signals from HCPs’ devices and delivers ads based on this data.

Photos of Sharron Rouse and Shoshana Lipson two of Health Union’s 2023 Social Health Award winners, at Digital Pharma East 2023

Patient Leader Perspectives: Co-Design with ‘Patients from the Start’

November 1, 2023

These two accomplished patient leaders combined their experiences and perspectives to explain how industry can integrate “patients from the start.”

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Migraine Patient-Reported Survey Data

December 16, 2020

New Health Union survey data show patients experience a very high number of symptoms and triggers, reinforcing that migraine is “more than just a headache.”

Inflammatory Bowel Disease Patient-Reported Survey Data

December 11, 2020

New survey data from Health Union reveals that half of respondents living with inflammatory bowel disease experience symptoms 15+ days per month.

HIV Patient-Reported Survey Data

December 7, 2020

New survey data shows 90% of people living with HIV feel controlled on their current treatment plan, but continue to struggle with great challenges.

Healthcare Industry Thought Leadership

Contact